Guo Q, He Y, Sun L, Kong C, Cheng Y, Zhang G. In silico detection of potential prognostic circRNAs through a re-annotation strategy in ovarian cancer. Oncol Lett. 2019;17(4):3677–86.
Wang Q, Lu Z, Ma J, Zhang Q, Wang N, Qian L, et al. Six-mRNA risk score system and nomogram constructed for patients with ovarian cancer. Oncol Lett. 2019;18(2):1235–45.
Hou Y, Wang Y, Xu S, Qi G, Wu X. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data. Mol Med Rep. 2019;20(1):281–91.
Zhuang H, Cheng L, Wang Y, Zhang YK, Zhao MF, Liang GD, et al. Dysbiosis of the gut microbiome in lung Cancer. Front Cell Infect Microbiol. 2019;9:112.
Kulbe H, Otto R, Darb-Esfahani S, Lammert H, Abobaker S, Welsch G, et al. Discovery and validation of novel biomarkers for detection of epithelial ovarian Cancer. Cells Basel. 2019;8(7):713.
Jiang Y, Lyu T, Che X, Jia N, Li Q, Feng W. Overexpression of SMYD3 in ovarian Cancer is associated with ovarian Cancer proliferation and apoptosis via Methylating H3K4 and H4K20. J Cancer. 2019;10(17):4072–84.
Zheng J, Zhou Y, Li XJ, Hu JM. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Eur Rev Med Pharmacol Sci. 2019;23(16):6839–48.
Harrington BS, Annunziata CM. NF-kappaB Signaling in Ovarian Cancer. Cancers (Basel). 2019;11:8.
Mohamed NE, Hay T, Reed KR, Smalley MJ, Clarke AR. APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression. BMC Cancer. 2019;19(1):677.
Li L, Gu H, Chen L, Zhu P, Zhao L, Wang Y, et al. Integrative network analysis reveals a MicroRNA-based signature for prognosis prediction of epithelial ovarian Cancer. Biomed Res Int. 2019;2019:1056431.
Zhao J, Huang J, Geng X, Chu W, Li S, Chen ZJ, et al. Polycystic ovary syndrome: novel and hub lncRNAs in the insulin resistance-associated lncRNA-mRNA network. Front Genet. 2019;10:772.
Gao YC, Zhou XH, Zhang W. An ensemble strategy to predict prognosis in ovarian Cancer based on gene modules. Front Genet. 2019;10:366.
Wang L, Ni S, Du Z, Li X. A six-CpG-based methylation markers for the diagnosis of ovarian cancer in blood. J Cell Biochem. 2020;121(2):1409–19.
Mase S, Shinjo K, Totani H, Katsushima K, Arakawa A, Takahashi S, et al. ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer. Cancer Sci. 2019;110(3):1105–16.
Groot KR, Sevilla LM, Nishi K, DiColandrea T, Watt FM. Kazrin, a novel periplakin-interacting protein associated with desmosomes and the keratinocyte plasma membrane. J Cell Biol. 2004;166(5):653–9.
Mu XQ, Liu BB, Hui E, Huang W, Yao LC, Duo LB, et al. A rapid loop-mediated isothermal amplification (LAMP) method for detection of the macrolide-streptogramin type B resistance gene msrA in Staphylococcus aureus. J Glob Antimicrob Resist. 2016;7:53–8.
Sevilla LM, Nachat R, Groot KR, Watt FM. Kazrin regulates keratinocyte cytoskeletal networks, intercellular junctions and differentiation. J Cell Sci. 2008;121(Pt 21):3561–9.
Zhou YJ, Zhu S, Yang DH, Zhao DD, Li JJ, Liu SL. Characterization of Klebsiella sp. strain S1: a bacterial producer of secoisolariciresinol through biotransformation. Can J Microbiol. 2017;63(1):1–10.
Chhatriwala MK, Cipolat S, Sevilla LM, Nachat R, Watt FM. Exons 5-15 of kazrin are dispensable for murine epidermal morphogenesis and homeostasis. J Invest Dermatol. 2012;132(8):1977–87.
Li QH, Jin G, Wang JY, Li HN, Liu H, Chang XY, et al. Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration. Sci Rep. 2016;6:29556.
Li FF, Han Y, Shi S, Li X, Zhu XD, Zhou J, et al. Characterization of transcriptional repressor gene MSX1 variations for possible associations with congenital heart diseases. PLoS One. 2015;10(11):e0142666.
Dong J, Xu M. A 19miRNA support vector machine classifier and a 6miRNA risk score system designed for ovarian cancer patients. Oncol Rep. 2019;41(6):3233–43.
Xie H, Xu H, Hou Y, Cai Y, Rong Z, Song W, et al. Integrative prognostic subtype discovery in high-grade serous ovarian cancer. J Cell Biochem. 2019;120(11):18659–66.
Luo M, Zhou L, Zhan SJ, Cheng LJ, Li RN, Wang H, et al. ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway. Biochem Biophys Res Commun. 2019;513(2):528–33.
Zhao H, Sun Q, Li L, Zhou J, Zhang C, Hu T, et al. High expression levels of AGGF1 and MFAP4 predict primary platinum-based Chemoresistance and are associated with adverse prognosis in patients with serous ovarian Cancer. J Cancer. 2019;10(2):397–407.
Feng Y, Hang W, Sang Z, Li S, Xu W, Miao Y, et al. Identification of exosomal and nonexosomal microRNAs associated with the drug resistance of ovarian cancer. Mol Med Rep. 2019;19(5):3376–92.
Goicoechea SM, Zinn A, Awadia SS, Snyder K, Garcia-Mata R. A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells. J Cell Sci. 2017;130(6):1064–77.
Li T, Ferns K, Yan ZQ, Yin SY, Kou JJ, Li D, et al. Acanthopanax senticosus: photochemistry and anticancer potential. Am J Chin Med. 2016;44(8):1543–58.
Chen Y, Bi F, An Y, Yang Q. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer. J Cell Biochem. 2019;120(9):14444–54.
Tian X, Guan W, Zhang L, Sun W, Zhou D, Lin Q, et al. Physical interaction of STAT1 isoforms with TGF-beta receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer. J Exp Clin Cancer Res. 2018;37(1):103.
Ferrero H, Corachan A, Aguilar A, Quinonero A, Carbajo-Garcia MC, Alama P, et al. Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality. Hum Reprod. 2019;34(7):1302–12.
Bi X, Zhai Z, Wang S. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis. Gen Physiol Biophys. 2019;38(3):205–14.
Li J, Yue H, Yu H, Lu X, Xue X. Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer. J Ovarian Res. 2019;12(1):47.
Liu S, Matsuzaki J, Wei L, Tsuji T, Battaglia S, Hu Q, et al. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. J Immunother Cancer. 2019;7(1):156.
Um H, Tixier F, Bermudez D, Deasy JO, Young RJ, Veeraraghavan H. Impact of image preprocessing on the scanner dependence of multi-parametric MRI radiomic features and covariate shift in multi-institutional glioblastoma datasets. Phys Med Biol. 2019;64(16):165011.
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT. Candido dos Reis FJ, de Sousa CB, Tiezzi DG, de Andrade JM, Koti M, squire JA: increased STAT1 expression in high grade serous ovarian Cancer is associated with a better outcome. Int J Gynecol Cancer. 2018;28(3):459–65.
Li N, Zhan X. Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics. EPMA J. 2019;10(2):153–72.
Ma SY, Wei P, Qu F. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves AS a risk factor for poor prognosis of epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2019;23(11):4629–41.
Wang X, Han L, Zhou L, Wang L, Zhang LM. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network. Oncol Rep. 2018;40(5):2659–73.
Hinchcliff E, Paquette C, Roszik J, Kelting S, Stoler MH, Mok SC, et al. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature. Cancer Immunol Immunother. 2019;68(9):1515–26.
Wu L, Shang W, Zhao H, Rong G, Zhang Y, Xu T, et al. In Silico screening of circulating MicroRNAs as potential biomarkers for the diagnosis of ovarian Cancer. Dis Markers. 2019;2019:7541857.